(Q40860720)

24 September 2017

1 reference

title

Acute myelogenous leukaemia (English)

1 reference

24 September 2017

1 reference

Pinto A

1

1 reference

24 September 2017

Zulian GB

series ordinal

2

1 reference

24 September 2017

Archimbaud E

series ordinal

3

1 reference

24 September 2017

publication date

1 February 1998

1 reference

Critical Reviews in Oncology Hematology

24 September 2017

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

161-164

1 reference

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Disappointments in treating acute leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Biology of acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without gran

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2910029-4

7 January 2021

10.1016/S1040-8428(97)10029-4

Identifiers

DOI

1 reference

24 September 2017

1 reference